We thus profiled a pair of epithelial ovarian cancer cell lines with different metastatic potentials [5] by using proteomics, and discovered that phospholipase A2-activating protein (PLAA) was downregulated in highly metastatic ovarian cancer cells. This evidence concerns the gene PLAA and ovarian cancer.